Autotransfusion Devices Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Autotransfusion Devices Industry Market Size Be by 2025?
The market for autotransfusion devices has consistently expanded in previous years. There's an expected rise from $1.21 billion in 2024 to $1.26 billion in 2025, marking a compound annual growth rate (CAGR) of 4.4%. The growth witnessed in the past can be credited to a surge in surgical operations, a rise in the incidence of cardiovascular diseases, more orthopedic surgeries and joint replacements, a focus on the safety of patients, as well as initiatives to cut down the expenses of blood transfusion.

What's the Long-Term Growth Forecast for the Autotransfusion Devices Market Size Through 2029?
Robust expansion is anticipated in the autotransfusion devices market in the coming years, with projections suggesting a market growth to $1.67 billion in 2029 with a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this surge during the forecast period are an increasing elderly population, the broadening of ambulatory surgical centers, an emphasis on blood conservation in obstetrics, and acceptance in progressing healthcare markets. Technological progress in blood processing, advanced sensors integration, device customization for various procedures, single-donor closed-loop systems, and device miniaturization are significant trends expected during the forecast period.

View the full report here:
https://www.thebusinessresearchcompany.com/report/autotransfusion-devices-global-market-report

What Are the Key Growth Drivers Fueling the Autotransfusion Devices Market Expansion?
The amplifying occurrence of cardiovascular illnesses is set to boost the development of the autotransfusion device market in the future. Cardiovascular diseases are categorized as conditions disturbing the heart and blood vessels. Autotransfusion devices have played a significant role in reducing the dependence on allogeneic blood transfusions. Unlike an allogeneic transfusion which uses blood from external donors, autotransfusion enables the re-transfusion of the patient's own blood, which lessens the probability of adverse reactions and complications associated with donor-based transfusions. For example, the Heart Disease and Stroke Statistics-2022 Update report by the American Heart Association, a non-profit organization based in the US, shows that cardiovascular diseases remain the primary cause of death worldwide, claiming approximately 17.9 million lives each year. As a result, the growing occurrence of cardiovascular diseases is promoting the expansion of the autotransfusion device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10275&type=smp

What Are the Key Trends Driving Autotransfusion Devices Market Growth?
Prominent players in the autotransfusion devices market are pioneering novel products like advanced intelligent control software to augment efficiency and customer experience. The software update, dubbed Intelligent Control, presents key advantages to users that can simplify procedures, thereby promoting heightened efficiency and superior user experience. For example, in March 2023, Haemonetics, a healthcare corporation based in the US, secured FDA 510 (K) approval for its revolutionary Intelligent Control software designed for the Cell Saver Elite+ autotransfusion system. The Cell Saver Elite+ autotransfusion system aims to aid hospitals in recovering a patient's blood during surgeries that are likely to result in medium to high blood loss, encompassing cardiac, orthopedic, trauma, transplant, vascular, and OBGYN surgeries. The innovative Intelligent Control software illustrates a significant leap forward in Haemonetics' Cell Salvage platform and is a testament to the company's dedication to advancing innovative solutions for improved patient outcomes.

How Is the Autotransfusion Devices Market Segmented?
The autotransfusion devices market covered in this report is segmented -

1) By Product Type: Autotransfusion Systems, Consumables And Accessories
2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications
3) By End-Use: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Autotransfusion Systems: Surgical Autotransfusion Systems, Emergency Autotransfusion Systems, Continuous Flow Autotransfusion Systems
2) By Consumables And Accessories: Collection Reservoirs, Blood Filters, Tubing Sets, Pumps, Anticoagulants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10275&type=smp

Which Companies Are Leading the Charge in Autotransfusion Devices Market Innovation?
Major companies operating in the autotransfusion devices market include Becton dic*kinson And Company, Medtronic plc, LivaNova plc, Haemonetics Corporation, Fresenius SE & Co KGaA, Terumo Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, GE HealthCare Technologies Inc., Cerus Corporation, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd., Getinge AB, Beijing ZKSK Technology Co. Ltd., Braile Biomédica, Redax S.p.A., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Gen World Medical Devices Corporation, Soma Technology International LLC, Beijing Jingjing Medical Equipment Co. Ltd., Johnson & Johnson Inc., Sorin Group, Baxter International Inc., Dideco, Nipro Corporation

Which Regions Are Leading the Global Autotransfusion Devices Market in Revenue?
North America was the largest region in the autotransfusion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10275

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.